Meleth S, Whitehead N, Evans TS, Lux L. Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin. AHRQ (US Agency for Healthcare Research and Quality); 2013. Links Full report Related Documents None Abstract Objectives This technology assessment reports the results of our review of… Read more »
Tagged: AHRQ TAP
Technology Assessment of Molecular Pathology Testing for the Estimation of Prognosis for Common Cancers
Meleth S, Reeder-Hayes K, Ashok M, Clark R, Funkhouser W, Wines R, Hill C, Shanahan E, McClure E, Burson K, Coker-Schwimmer M, Garge N, Jonas DE. Technology Assessment of Molecular Pathology Testing for the Estimation of Prognosis for Common Cancers. AHRQ (US Agency for Healthcare Research and Quality); 2014. Links Full report Related Documents… Read more »
Definition of Treatment-Resistant Depression in the Medicare Population
Gaynes BN, Asher G, Gartlehner G, Hoffman V, Green J, Boland E, Lux L, Weber RP, Randolph C, Bann C, Coker-Schwimmer E, Viswanathan M, Lohr KN. Definition of Treatment-Resistant Depression in the Medicare Population. Technology Assessment Program. Project ID: PSYT0816. (Prepared by RTI International-University of North Carolina (RTI-UNC) Evidence-based Practice Center under Contract No. HHSA290-01-500011I_HHSA29032006T.)… Read more »